Thomas Civik - Mar 24, 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Thomas Civik
Stock symbol
PYXS
Transactions as of
Mar 24, 2023
Transactions value $
$0
Form type
4
Date filed
3/28/2023, 04:41 PM
Previous filing
May 16, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +139K +208.52% $0.00 206K Mar 24, 2023 Direct F1
holding PYXS Common Stock 15.7K Mar 24, 2023 By Civik Family Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
F2 These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.